Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy

British Journal of Pharmacology

Volumn 118, Issue 3, 1996, Pages 811-819

  Saleh, Tania Silvia Fröde ^a   Calixto, João Batista ^a   Medeiros, Yara Santos ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anti asthmatic drugs; Carrageenin; Cromolyn; Inflammation; Mouse pleurisy; Salbutamol; Theophylline

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; CARRAGEENAN; CROMOGLYCATE DISODIUM; SALBUTAMOL; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PLEURA CAVITY; PLEURA FLUID; PLEURISY; PRIORITY JOURNAL;

EID: 0029982217     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15472.x     Document Type: Article

References (41)

1. AALBERS, R., SMITH, M. & TIMENS, W. (1993). Immunohistology in bronchial asthma. Respir. Med., 87B: (suppl.) 13-21.
2. BANNER, K.H. & PAGE, C. (1995). Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs. Br. J. Pharmacol., 114, 93-98.
3. BARNES, P.J. (1989). A new approach to the treatment of asthma. N. Engl. J. Med., 321, 1517-1527.
4. BEASLEY, R., ROCHE, W.R., ROBERTS, J.A. & HOLGATE, S.T. (1989). Cellular events in the bronchi in mild asthma and after provocation. Am. Rev. Respir. Dis., 139, 806-817.
5. BECKER, J.W. & BIERMAN, C.W. (1994). Prophylactic anti-asthma drugs. In Drugs in the Lung. ed. Page, C.P. & W.J. Metzer, C.P., pp. 221-249, New York: Raven Press.
6. BERNSTEIN, J.A. & BERNSTEIN, I.L. (1993). Cromolyn and nedocromil. Immunol. Allergy Clin. North Am., 13, 891-902.
7. BRITO, F.B. (1989). Pleurisy and pouch models of acute inflammation. In Pharmacological Methods in the Control of Inflammation. ed. Liss, A. R., pp. 173-228, Dagenham: Rhone Poulenc Ltd.
8. CRESCIOLLI, S., SPINAZZI, A., PLEBANI, M., MAPP, C.E., BOSCHETTO, P. & FABBRI, L.M. (1981). Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. Ann. Allergy, 66, 245-251.
9. CHURCH, M.K., HUTSON, P.A. & HOLGATE, S.T. (1993). Nedocromil sodium blocks the early and late phases of allergen challenge in a guinea pig model of asthma. J. Allergy Clin. Immunol., 92, 177-182.
10. ERJEFALT, L. & PERSSON, C.G. (1991). Pharmacological control of plasma exudation into tracheobronchial airways. Am. Rev. Respir. Dis. 143, 1008-1014.
11. GERN, J.E. & LEMANSKE, R.F. (1993). Beta-adrenergic agonist therapy. Immunol. Allergy Clin. North Am., 13, 839-860.
12. HARGREAVES, F.E., RYAN, A. & THOMPSON, N.C. (1981). Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J. Allergy Clin. Immunol., 68, 347-340.
13. HENRIQUES, M.G. (1993). Estudo da Reação Inflamatória induzida por carragenina em camundongos. Departamento de Fisiologia e Farmacodinâmica. Fundação Oswaldo Cruz. R.J. Brazil. PhD. Thesis, pp. 1-181.
14. HENRIQUES, M.G., RAE, G., CORDEIRO, R.S.B., WILLIAMS, T.J. (1992). Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse. Br. J. Pharmacol., 106, 579-582.
15. HOLIAN, A., HAMILTON, R. & SCHEULE, R.K. (1991). Mechanistic aspects of cromolyn sodium action on the alveolar macrophage: inhibition of stimulation by soluble agonists. Agents Actions, 33, 318-325.
16. KEMP, J.P. (1993). Approaches to asthma management. Arch. Intern. Med., 153, 805-812.
17. KOWASKI, M.L., SLIWISKA-KOWASLSKI & KALINER, M.A. (1990). Neurogenic inflammation, vascular permeability and mast cells. II Additonal evidence indicating that mast cells are not involved in neurogenic inflammation. J. Immunol., 145, 1214-1221.
18. LO, T.N., ALMEIDA, A.P., BEAVEN, M.A. (1982). Dextran and carrageenin evoke different inflammatory responses in rat with respect to composition of infiltrates and effect of indomethacin. J. Pharmacol. Exp. Ther., 221, 261-267.
19. MILGROM, H. (1993). Theophylline. Immunol. Allergy Clin. North. Am., 13, 819-838.
20. MILGROM, H. & BENDER, B. (1993). Current Issues in the use of theophylline. Respir. Dis., 147, 533-539.
21. MORLEY, J.K. (1994). Channel openers and suppression of airway hyperactivity. Trends Pharmacol. Sci., 15, 463-468.
22. NICHOLAS, H., BLACK, P., COUCH, R., KENNEDY, J. & BRIANT, R. (1993). Theophylline target concentration in severe airway obstruction- 10 or 20 mg/L? Clin. Pharmacocinet., 25, 495-505.
23. O'BYRNE, P.M., DOLOVICH, J. & HARGREAVE, F.E. (1987). Late asthmatic responses. Am. Rev. Respir. Dis., 136, 740-751.
24. OKAYAMA, Y. & CHURCH, M.K. (1992). Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Arch. Allergy Immunol., 97, 316-225.
25. PACHECO, Y., HOSNI, R., CHABANNES, B., GORMAND, F., MOLIERE, P., GROSCLAUDE, M., PIPERNO, D., LAGARDE, M. & PERRIN-FAYOLLE, M. (1992). Leukotrien B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2-agonist therapy. Eur. J. Clin. Invest., 22, 732-739.
26. PAGE, C.P. (1991). One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta-2-agonists. Lancet, 337, 717-720.
27. PAGGIARO, P.L., DENTE, F.L., VAGAGGINI, B., BACCI, E., TALINI, D., TESTI, R., MAPP, C.E., FABBRI, L.M. & GIUNTINI, C. (1991). Salbutamol plus beclomethasone dipropionate, but not salbutamol alone, completely prevent early and late asthmatic responses to allergen. Respir. Med., 85, 401-406.
28. PAUWELS, R.A. (1989). New aspects of therapeutic potential of theophylline in asthma. J. Allergy Clin. Immunol., 83, 548-553.
29. PAUWELS, R.A. & PERSON, C.G.A. (1991). Xanthines. In Asthma: its Pathology and Treatment. ed. Kaliner, M.A., Barnes, P.J. & Person, C.G.A. pp. 503-521. New York: Marcel Decker.
30. RAEBURN, D., UNDERWOOD, S., LEWIS, S., WOODMAN, V., BATTRAM, C., TOMKINSON, A., SHARMA, S., JORDAM, R., SOUNESS, J., WEBBER, S. & KARLSSON, J. (1994). Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br. J. Pharmacol., 113, 1423-1431.
31. SCHLOSBERG, M., LIU, M.C. & BOCHNER, B.S. (1993). Pathophysiology of asthma. Immunol. Allergy Clin. North Am., 13, 721-743.
32. SCHRIER, D.J., LESCH, M.E., WRIGHT, C.D. & GILBERTESEN, R.S. (1990). The anti-inflammatory effects of adenosine receptor agonists on the carrageenin-induced pleural inflammatory response in rats. J. Immunol., 145, 1874-1879.
33. SMITH, H. (1992). Asthma, inflammation, eosinophils and bronchial hyperesponsiveness. Clin. Exp. Allergy., 22, 187-197.
34. SPATAFORA, M., CHIAPPARA, G., MERENDINO, A.M., D'AMICO, D., BELLIA, V. & BONSIGNORE, G. (1994). Theophylline suppresses the release of tumour necrosis factor-α by blood monocytes and alveolar macrophages. Eur. Respir. J., 7, 223-228.
35. SULLIVAN, P., BEKIR, S., JAFFAR, Z., PAGE, C., JEFFERY, P. & COSTELLO, J. (1994). Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet, 343, 1006-1008.
36. SVENJO, E. (1990). The hamster cheek pouch as a model in microcirculation research. Eur. Respir. J., 12P: (suppl.) 595-600.
37. TAINSH, K.R., LAU, H.Y., LIU, W.L. & PEARCE, F.L. (1991). The human skin mast cell: a comparison with the human lung cell and a novel mast cell type, the uterine mast cell. Agents Actions, 33, 16-19.
38. TARAYRE, J.P., ALIAGA, M., BARBARA, M., TISSEYRE, N., VIEU, S. & TISNE-VERSAILLES, J. (1991). Pharmacological modulation of a model of bronchial inflammation after aerosol induced active anaphylactic shock in conscious guinea pigs. Int. J. Immunopharmacol., 13, 349-356.
39. TORPHY, T.J. & UNDEM, B.J. (1991). Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax, 46, 512-523.
40. YAMADA, N., KADOWASKI, S. & UMEZU, S. (1992). Development of an animal model of late asthmatic response in guinea pigs and effects of anti-asthmatic drugs. Prostaglandins, 43, 507-521.
41. YUKAWA, T., KROGEL, C., CHANEZ, P., DENT, G., UKENA, D., CHUNG, K.F. & BARNES, P.J. (1989). Effect of theophylline and adenosine on eosinophil function. Am. Rev. Respir. Dis., 140, 327-333.